Author | Remarks | # of patients | Prevalence of CAD | Sensitivity (%) | Specificity (%) | Accuracy (%) |
---|---|---|---|---|---|---|
Schwitter et al. [7] | upslope | 57 | 65% | 86% | 85% | 86% |
Nagel et al. [90] | upslope | 84 | 51% | 88% | 90% | 89% |
Ishida et al. [82] | Â | 104 | 74% | 90% | 85% | 88% |
Wolff et al. [78] | low dose group | 26 | 54% | 93% | 75% | 85% |
Giang et al. [79] | group 2 and 3 | 44 | 64% | 93% | 75% | 86% |
Paetsch et al. [83] | upslope | 79 | 67% | 91% | 62% | 81% |
Plein et al. [91] | upslope | 92 | 64% | 88% | 82% | 86% |
Sakuma et al. [8] | visual | 40 | 53% | 81% | 68% | 75% |
Klem et al. [46] | visual: perfusion and late enhancement | 92 | 40% | 89% | 87% | 88% |